trending Market Intelligence /marketintelligence/en/news-insights/trending/6tvbjv-u3pf09popkon_sw2 content esgSubNav
In This List

2 Biostage directors resign

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


2 Biostage directors resign

Holliston, Mass.-based Biostage Inc. said John Canepa and Blaine McKee resigned from the company's board.

McKee, currently executive vice president and chief business officer of ImmunoGen Inc., had been on the Biostage board since March 10, 2016, according to S&P Capital IQ.

Canepa, the CFO of Asterand Bioscience Inc., joined the Biostage board in 2013.

Biostage, which is searching for replacements, said the resignations were not the result of any disagreement with the company.